Literature DB >> 14583618

The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver.

Sofia L Larsson1, Josefin Skogsberg, Johan Björkegren.   

Abstract

The assembly and secretion of very low density lipoproteins (VLDL) require microsomal triglyceride transfer protein (MTP). Recent evidence also suggests a role for the low density lipoprotein (LDL) receptor in this process. However, the relative importance of MTP in the two steps of VLDL assembly and the specific role of the LDL receptor still remain unclear. To further investigate the role of MTP and the LDL receptor in VLDL assembly, we bred mice harboring "floxed" Mttp alleles (Mttpflox/flox) and a Cre transgene on a low-density lipoprotein receptor-deficient background to generate mice with double deficiency in the liver (Ldlr-/- MttpDelta/Delta). In contrast to the plasma of Ldlr+/+ MttpDelta/Delta mice, the plasma of Ldlr-/- MttpDelta/Delta mice contained apoB100. Accordingly, Ldlr-/- MttpDelta/Delta but not Ldlr+/+ MttpDelta/Delta hepatocytes secreted apoB100-containing lipoprotein particles. The secreted lipoproteins were of LDL and HDL sizes but no VLDL-sized lipoproteins could be detected. These findings indicate that hepatic LDL receptors function as "gatekeepers" targeting dense apoB100-containing lipoproteins for degradation. In addition, these results suggest that very low levels of MTP are insufficient to mediate the second step but sufficient for the first step of VLDL assembly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14583618     DOI: 10.1074/jbc.M303057200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

Review 2.  Hepatic regulation of apolipoprotein B.

Authors:  Rita Kohen Avramoglu; Khosrow Adeli
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

3.  Apolipoprotein B-containing lipoprotein assembly in microsomal triglyceride transfer protein-deficient McA-RH7777 cells.

Authors:  Yanwen Liu; Medha Manchekar; Zhihuan Sun; Paul E Richardson; Nassrin Dashti
Journal:  J Lipid Res       Date:  2010-02-24       Impact factor: 5.922

Review 4.  Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk.

Authors:  Sebastiano Calandra; Patrizia Tarugi; Helen E Speedy; Andrew F Dean; Stefano Bertolini; Carol C Shoulders
Journal:  J Lipid Res       Date:  2011-08-23       Impact factor: 5.922

5.  Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB.

Authors:  Daniel A Blasiole; Angie T Oler; Alan D Attie
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

6.  Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.

Authors:  Lance A Johnson; Michael K Altenburg; Rosemary L Walzem; Lori T Scanga; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

7.  ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice.

Authors:  Zhouji Chen; Elizabeth P Newberry; Jin Y Norris; Yan Xie; Jianyang Luo; Susan M Kennedy; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2008-06-02       Impact factor: 5.922

8.  Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production.

Authors:  Meihui Pan; Arthur I Cederbaum; Yuan-Li Zhang; Henry N Ginsberg; Kevin Jon Williams; Edward A Fisher
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

Review 9.  Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease.

Authors:  Sven-Olof Olofsson; Olov Wiklund; Jan Borén
Journal:  Vasc Health Risk Manag       Date:  2007

10.  Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion.

Authors:  Eric Fisher; Elizabeth Lake; Roger S McLeod
Journal:  J Biomed Res       Date:  2014-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.